Skip to main content
PBF logo

PBF — Investor Relations & Filings

Ticker · 1760 ISIN · TW0001760007 LEI · 54930078VUU2LBPR2729 TW Manufacturing
Open in API
Filings indexed 1,562 across all filing types
Latest filing 2022-12-14 Director's Dealing
Country TW Taiwan
Listing TW 1760

About PBF

http://www.pbf.com.tw

Panion & BF Biotech Inc. is a biotechnology company focused on pharmaceutical research, development, and manufacturing. Founded in 1976, the firm operates across several core sectors, including new drug innovation, medical aesthetics, and nutritional supplements. It is recognized for its "Total Aging Management" strategy, which addresses the health needs of an aging population through a diverse product portfolio. Key offerings include treatments for chronic kidney disease, specifically phosphate binders, as well as dermatological drugs, hair care solutions, and rapid diagnostic technologies. The company integrates clinical-grade pharmaceutical standards into its consumer health and aesthetic products, serving markets in chronic disease care and preventative wellness.

Recent filings

Filing Released Lang Actions
111年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related information. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full annual or quarterly report, nor an announcement of voting results or dividends. The document is not a certification or a brief announcement but a detailed disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is consistent with insider shareholding disclosures.
2022-12-14 Chinese
111年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It provides specific data on share counts, pledged shares, and related parties' holdings. The content focuses on insider shareholdings and changes, which aligns with reporting of personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document length is about 3,124 characters, which is sufficient for a detailed insider shareholding report. Therefore, the document is best classified as a Director's Dealing report.
2022-12-14 Chinese
澄清媒體有關本公司之報導
Regulatory Filings Classification · 95% confidence The document is a short announcement (838 characters) from a company clarifying media reports about its financial performance and stating that any financial figures will be officially released through regulatory filings. It does not contain any actual financial data or detailed report content. It is essentially a regulatory announcement to ensure investor awareness and compliance. According to the rules, such short clarifications or announcements that do not contain substantive financial data or reports should be classified as Regulatory Filings (RNS).
2022-12-13 Chinese
111年12月法人說明會簡報 — 176020221212E001.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed corporate presentation of a biotechnology company, including extensive financial data, product descriptions, business units, and growth analysis. It contains comprehensive financial tables with operating revenue, profit, R&D expenses, and sales breakdowns over multiple years and periods, indicating substantive financial data and analysis. The content is not a brief announcement or a certification but a full report on company performance and business segments. The length (13,785 characters) and depth of financial and operational information suggest it is a comprehensive periodic financial report rather than a short announcement or presentation. The presence of financial analysis, product and business unit descriptions, and multi-year financial data aligns with the characteristics of an Interim / Quarterly Report (IR). There is no indication that this is an Annual Report (10-K) or a full year report, and the data includes partial year (e.g., 2022/1-9) figures, consistent with an interim report. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2022
2022-12-12 Chinese
111年12月法人說明會簡報 — 176020221212M001.pdf
Annual Report Classification · 95% confidence The document is a detailed corporate presentation including company background, financial analysis with multi-year financial data, product and business unit descriptions, and growth strategies. It contains comprehensive financial tables with revenue, profit, R&D expenses, and sales breakdowns over multiple years, as well as detailed descriptions of business units and product development. There is no indication that this is a short announcement or a certification. The length (7729 characters) and content suggest it is a full report rather than a brief announcement or regulatory filing. The document does not appear to be a quarterly or interim report since it covers multiple years and strategic information, nor is it a call transcript or AGM material. It is consistent with an Annual Report (10-K) type document, providing a full overview of company activities and financial performance over a fiscal year or multiple years. 9M 2022
2022-12-12 Chinese
111年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled or held investor presentation (法人說明會) for a company, including date, time, location, and links to presentation materials in Chinese and English. The content focuses on the announcement and provision of investor presentation materials rather than a full report or financial statements. The document length is short (717 characters), and it primarily serves as an announcement or summary of an investor presentation event. Therefore, the most appropriate classification is Investor Presentation (IP).
2022-12-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.